For decades, healthcare has operated in silos. The diagnostic lab discovers a cancer mutation. The data scientist identifies a pattern. The oncologist prescribes treatment. Each brilliant in their domain. Each [...]

The landscape of precision diagnostics in the United Kingdom is undergoing a fundamental transformation. As we progress through 2026, three major developments are converging to redefine how diseases are detected, [...]

THE NHS App has crossed a major threshold, signalling a shift in how patients across England are accessing care. According to NHS England’s latest year-end update, the NHS App now [...]

In a major step toward digital-first care, the UK has launched TrustX Health, a national program to verify, govern and deploy “Agentic AI” technologies across the NHS. This initiative—led by [...]

Artificial intelligence is increasingly being embedded into the operational fabric of the NHS, not as a standalone innovation, but as part of core digital infrastructure designed to improve productivity, efficiency [...]

The UK’s health data ecosystem is entering a new phase, one where population health is no longer analysed solely in hindsight, but increasingly anticipated through predictive intelligence. At the centre [...]

Natera is deepening its footprint in precision oncology with the acquisition of Foresight Diagnostics in an all-stock deal worth up to $450 million. This move brings together Natera’s personalised [...]